Decision coming on biotech KineMed's stalled IPO

KineMed Inc. could opt to withdraw its planned $41 million IPO after investors dissed the Emeryville biotech company’s desired price...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.